References
- Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, et al. Expression of TERT in early premalignant lesion and a subset of cells in normal tissues. Nat Genet 1998;19:182–6.
- Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, et al. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocel-lular carcinoma. Br J Cancer 2000;82:833–7.
- Xu D, Gruber A, Peterson C, Pisa P. Telomerase activity and the expression of telomerase components in acute myelo-genous leukaemia. Br J Hematol 1998;102:1367–75.
- Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-poly-merase chain reaction assay. Chin Cancer Res 2000;6: 452–9.
- de Kok JB, Ruers TJ, van Muijen GN, van Bokhoven A, Willems HL, Swinkels DW. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Chin Chem 2000;46:313–8.
- Buchler P, Conejo-Garcia JR, Lehmann G, Muller M, Emrich T, Reber HA, et al. Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders. Pancreas 2001;22: 331–40.
- Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, Pugazhenthi U, et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 2002;84:120 —5 .
- Marchetti A, Pellegrini C, Buttitta F, Falleni M, Romagnoli S, Felicioni L, et al. Prediction of survival in Stage I lung carcinoma patients by telomerase function evaluation. Lab Invest 2002;82:729–36.
- Miura N, Shiota G, Nakagawa T. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 2003; 64:430–4.
- Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez 0, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Chin Cancer Res 2001;7:2821–5.
- Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 2001;945: 172–8.
- Hasselmann DO, Rappl G, Rossler M, Ugurel S, Tilgen W, Reinhold U, et al. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Oncol Rep 2001;8: 115–8.